Grifols ROA 2012-2018 | GRFS

Current and historical return on assets (ROA) values for Grifols (GRFS) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Grifols ROA for the three months ending September 30, 2018 was 6.24%.
Grifols ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2018-09-30 $0.51B $13.70B 3.92%
2018-06-30 $0.66B $13.64B 5.33%
2017-06-30 $0.61B $12.23B 5.23%
2017-03-31 $0.61B $12.48B 5.39%
2016-12-31 $0.60B $11.21B 5.63%
2016-09-30 $0.60B $10.68B 5.64%
2016-06-30 $0.60B $10.78B 5.69%
2016-03-31 $0.59B $10.19B 5.69%
2015-12-31 $0.59B $10.66B 5.70%
2015-09-30 $0.60B $10.21B 5.67%
2015-06-30 $0.59B $10.06B 5.56%
2015-03-31 $0.58B $10.58B 5.49%
2014-12-31 $0.61B $11.23B 5.81%
2014-09-30 $0.56B $10.75B 5.86%
2014-06-30 $0.52B $9.98B 5.95%
2014-03-31 $0.51B $9.86B 6.16%
2013-12-31 $0.46B $7.76B 5.95%
2013-09-30 $0.43B $7.57B 5.68%
2013-06-30 $0.40B $7.63B 5.30%
2013-03-31 $0.36B $7.64B 4.82%
2012-12-31 $0.33B $7.24B 4.46%
2012-09-30 $0.26B $7.31B 3.45%
2012-06-30 $0.22B $7.60B 2.81%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $13.151B $4.878B
Grifols, S.A., operates in the pharmaceutical-hospital sector engaged in the research, development and retailing of plasma derivates, products for intravenous therapy, clinical nutrition, diagnostic and hospital logistics systems. The Company operates its business through three divisions: Bioscience Division, Diagnostic Division and Hospital Division. The Bioscience division is engaged in the research, development, production and commercialization of plasma derivates. Diagnostic Division focuses on researching, developing, manufacturing and marketing diagnostics products for laboratory analysis, including products for Hospital Blood Banks and Transfusion Centers. Hospital Division provides non-biological products used in hospital pharmacies, surgery, nutritional support, fluid therapy and for other therapeutic uses. Grifols, S.A. is based in Barcelona, Spain.
Stock Name Country Market Cap PE Ratio
Shire (SHPG) Ireland $52.737B 11.25
Zoetis (ZTS) United States $42.323B 28.98
Tilray (TLRY) United States $9.340B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $8.516B 12.22
Neurocrine Biosciences (NBIX) United States $7.634B 1683.60
Ionis Pharmaceuticals (IONS) United States $7.308B 0.00
Nektar Therapeutics (NKTR) United States $6.402B 9.18
Catalent (CTLT) United States $5.280B 22.15
Impax Laboratories (AMRX) United States $5.180B 0.00
Sage Therapeutics (SAGE) United States $4.814B 0.00
United Therapeutics (UTHR) United States $4.770B 7.80
Loxo Oncology (LOXO) United States $4.133B 0.00
TESARO (TSRO) United States $4.071B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.986B 14.76
FibroGen (FGEN) United States $3.227B 0.00
USANA Health Sciences (USNA) United States $2.879B 24.51
Endo (ENDP) Ireland $2.596B 3.98
Xencor (XNCR) United States $2.114B 0.00
Heron Therapeutics (HRTX) United States $2.071B 0.00
Endocyte (ECYT) United States $1.956B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.901B 256.83
Ironwood Pharmaceuticals (IRWD) United States $1.896B 0.00
Aerie Pharmaceuticals (AERI) United States $1.804B 0.00
Zogenix (ZGNX) United States $1.786B 0.00
Madrigal Pharmaceuticals (MDGL) United States $1.740B 0.00
PTC Therapeutics (PTCT) United States $1.683B 0.00
Corcept Therapeutics (CORT) United States $1.506B 22.10
Theravance Biopharma (TBPH) Cayman Islands $1.484B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.419B 19.95
Esperion Therapeutics (ESPR) United States $1.381B 0.00
Portola Pharmaceuticals (PTLA) United States $1.374B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.321B 0.00
Tricida (TCDA) United States $1.258B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.156B 0.00
TherapeuticsMD (TXMD) United States $1.078B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.963B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.800B 0.00
ImmunoGen (IMGN) United States $0.796B 0.00
Radius Health (RDUS) United States $0.721B 0.00
Collegium Pharmaceutical (COLL) United States $0.634B 0.00
Karyopharm Therapeutics (KPTI) United States $0.608B 0.00
Forty Seven (FTSV) United States $0.572B 0.00
Flexion Therapeutics (FLXN) United States $0.566B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.522B 0.00
ChemoCentryx (CCXI) United States $0.498B 39.40
Akebia Therapeutics (AKBA) United States $0.487B 0.00
Siga Technologies (SIGA) United States $0.476B 0.00
Dermira (DERM) United States $0.459B 0.00
GlycoMimetics (GLYC) United States $0.455B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.452B 0.00
Xeris Pharmaceuticals (XERS) United States $0.429B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.421B 24.85
Dova Pharmaceuticals (DOVA) United States $0.408B 0.00
Odonate Therapeutics (ODT) United States $0.402B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.395B 0.00
ArQule (ARQL) United States $0.390B 0.00
Tyme Technologies (TYME) United States $0.389B 0.00
Translate Bio (TBIO) United States $0.385B 0.00
KalVista Pharmaceuticals (KALV) United States $0.385B 0.00
CASI Pharmaceuticals (CASI) United States $0.372B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.362B 0.00
Aclaris Therapeutics (ACRS) United States $0.338B 0.00
OptiNose (OPTN) United States $0.333B 0.00
Tapimmune (MRKR) United States $0.326B 0.00
Aratana Therapeutics (PETX) United States $0.312B 0.00
Minerva Neurosciences (NERV) United States $0.309B 0.00
Concert Pharmaceuticals (CNCE) United States $0.293B 0.00
Majesco Entertainment (PTE) United States $0.293B 0.00
Depomed (ASRT) United States $0.273B 10.17
Mast Therapeutics (SVRA) United States $0.268B 0.00
IMV INC (IMV) Canada $0.266B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.263B 0.00
Affimed (AFMD) Germany $0.250B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.246B 0.00
Aldeyra Therapeutics (ALDX) United States $0.242B 0.00
Ocular Therapeutix (OCUL) United States $0.239B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.222B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.210B 0.00
Lannett Co Inc (LCI) United States $0.209B 1.82
AcelRx Pharmaceuticals (ACRX) United States $0.208B 0.00
Aquestive Therapeutics (AQST) United States $0.206B 0.00
Galectin Therapeutics (GALT) United States $0.204B 0.00
TAIWAN LIPOSOME (TLC) Taiwan $0.198B 0.00
Opexa Therapeutics (ACER) United States $0.195B 0.00
Zafgen (ZFGN) United States $0.189B 0.00
Calithera Biosciences (CALA) United States $0.187B 0.00
MEI Pharma (MEIP) United States $0.184B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.175B 0.00
ContraFect (CFRX) United States $0.171B 0.00
Nature's Sunshine Products (NATR) United States $0.170B 0.00
Recro Pharma (REPH) United States $0.170B 0.00
Neon Therapeutics (NTGN) United States $0.162B 0.00
Molecular Templates (MTEM) United States $0.160B 0.00
ElectroCore (ECOR) United States $0.151B 0.00
Redhill Biopharma (RDHL) Israel $0.150B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.149B 0.00
MediWound (MDWD) Israel $0.146B 0.00
Ardelyx (ARDX) United States $0.145B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.135B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.134B 0.00
Jounce Therapeutics (JNCE) United States $0.129B 0.00
DURECT (DRRX) United States $0.127B 0.00
Cardiome Pharma (CORV) Canada $0.125B 0.00
Adherex Technologies (FENC) United States $0.122B 0.00
ProNAi Therapeutics (SRRA) Canada $0.113B 0.00
Champions Oncology (CSBR) United States $0.113B 0.00
Iterum Therapeutics (ITRM) Ireland $0.110B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.099B 0.00
Immune Design (IMDZ) United States $0.097B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.096B 0.00
Melinta Therapeutics (MLNT) United States $0.094B 0.00
Synergy Pharmaceuticals (SGYP) United States $0.089B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.088B 0.00
CTI BioPharma (CTIC) United States $0.088B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.078B 0.00
Natural Alternatives (NAII) United States $0.077B 7.60
KemPharm (KMPH) United States $0.075B 0.00
Infinity Pharmaceuticals (INFI) United States $0.073B 0.00
Otonomy (OTIC) United States $0.072B 0.00
BioLineRx (BLRX) Israel $0.070B 0.00
Nivalis Therapeutics (ALPN) United States $0.066B 0.00
Achaogen (AKAO) United States $0.064B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.061B 0.00
Neos Therapeutics (NEOS) United States $0.059B 0.00
Avenue Therapeutics (ATXI) United States $0.053B 0.00
Forward Pharma (FWP) Denmark $0.052B 0.00
Genocea Biosciences (GNCA) United States $0.050B 0.00
Mannatechorporated (MTEX) United States $0.047B 0.00
Capnia (SLNO) United States $0.038B 0.00
Novan (NOVN) United States $0.036B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.036B 0.00
ProPhase Labs (PRPH) United States $0.036B 0.00
Heat Biologics (HTBX) United States $0.031B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.031B 0.00
Lipocine (LPCN) United States $0.030B 0.00
Trillium Therapeutics (TRIL) Canada $0.030B 0.00
SCYNEXIS (SCYX) United States $0.029B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.028B 0.00
PharmAthene (ALT) United States $0.028B 0.00
Xenetic Biosciences (XBIO) United States $0.024B 0.00
Biomerica (BMRA) United States $0.024B 0.00
Jaguar Animal Health (JAGX) United States $0.023B 0.00
HANCOCK JAFFE (HJLI) United States $0.022B 0.00
Aviragen Therapeutics (VXRT) United States $0.021B 0.00
Cyanotech (CYAN) United States $0.021B 0.00
Onconova Therapeutics (ONTX) United States $0.021B 0.00
Citius Pharmaceuticals (CTXR) United States $0.019B 0.00
Pain Therapeutics (PTIE) United States $0.019B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.018B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.017B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.017B 6.10
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.017B 0.00
ESSA Pharma (EPIX) Canada $0.016B 0.00
Shineco (TYHT) China $0.015B 1.65
Regulus Therapeutics (RGLS) United States $0.013B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.012B 0.00
Skyline Medical (AIPT) United States $0.011B 0.00
OncoGenex Pharmaceuticals (ACHV) United States $0.010B 0.00
Aradigm (ARDM) United States $0.008B 0.00
Apricus Biosciences (APRI) United States $0.008B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.008B 0.00
Midatech Pharma (MTP) United Kingdom $0.007B 0.00
RXi Pharmaceuticals (PHIO) United States $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.005B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.004B 0.00
Bio Blast Pharma (ORPN) Israel $0.004B 0.00
Bio-Path Holdings (BPTH) United States $0.004B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.003B 0.00
Intellipharmaceutics (IPCI) Canada $0.003B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00